These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 28854909

  • 1. A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study.
    Guilbot A, Bangratz M, Ait Abdellah S, Lucas C.
    BMC Complement Altern Med; 2017 Aug 30; 17(1):433. PubMed ID: 28854909
    [Abstract] [Full Text] [Related]

  • 2. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial.
    Gaul C, Diener HC, Danesch U, Migravent® Study Group.
    J Headache Pain; 2015 Aug 30; 16():516. PubMed ID: 25916335
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of nutraceuticals in migraine prophylaxis.
    D'Onofrio F, Raimo S, Spitaleri D, Casucci G, Bussone G.
    Neurol Sci; 2017 May 30; 38(Suppl 1):117-120. PubMed ID: 28527067
    [Abstract] [Full Text] [Related]

  • 4. Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study.
    Shrivastava R, Pechadre JC, John GW.
    Clin Drug Investig; 2006 May 30; 26(5):287-96. PubMed ID: 17163262
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
    Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-von Zepelin HH, Investigators.
    Cephalalgia; 2002 Sep 30; 22(7):523-32. PubMed ID: 12230594
    [Abstract] [Full Text] [Related]

  • 6. Open Label Prospective Experience of Supplementation with a Fixed Combination of Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine Prophylaxis.
    Vikelis M, Dermitzakis EV, Vlachos GS, Soldatos P, Spingos KC, Litsardopoulos P, Kararizou E, Argyriou AA.
    J Clin Med; 2020 Dec 27; 10(1):. PubMed ID: 33375459
    [Abstract] [Full Text] [Related]

  • 7. An observational study of fixed-dose Tanacetum parthenium nutraceutical preparation for prophylaxis of pediatric headache.
    Moscano F, Guiducci M, Maltoni L, Striano P, Ledda MG, Zoroddu F, Raucci U, Villa MP, Parisi P.
    Ital J Pediatr; 2019 Mar 12; 45(1):36. PubMed ID: 30871574
    [Abstract] [Full Text] [Related]

  • 8. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial.
    Maizels M, Blumenfeld A, Burchette R.
    Headache; 2004 Oct 12; 44(9):885-90. PubMed ID: 15447697
    [Abstract] [Full Text] [Related]

  • 9. The use of nutraceutics in children's and adolescent's headache.
    Sangermani R, Boncimino A.
    Neurol Sci; 2017 May 12; 38(Suppl 1):121-124. PubMed ID: 28527085
    [Abstract] [Full Text] [Related]

  • 10. A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine.
    Cady RK, Goldstein J, Nett R, Mitchell R, Beach ME, Browning R.
    Headache; 2011 May 12; 51(7):1078-86. PubMed ID: 21631494
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effectiveness of coenzyme Q10 in prophylactic treatment of migraine headache: an open-label, add-on, controlled trial.
    Shoeibi A, Olfati N, Soltani Sabi M, Salehi M, Mali S, Akbari Oryani M.
    Acta Neurol Belg; 2017 Mar 12; 117(1):103-109. PubMed ID: 27670440
    [Abstract] [Full Text] [Related]

  • 13. The synergistic effects of nano-curcumin and coenzyme Q10 supplementation in migraine prophylaxis: a randomized, placebo-controlled, double-blind trial.
    Parohan M, Sarraf P, Javanbakht MH, Foroushani AR, Ranji-Burachaloo S, Djalali M.
    Nutr Neurosci; 2021 Apr 12; 24(4):317-326. PubMed ID: 31241007
    [Abstract] [Full Text] [Related]

  • 14. Effect of coenzyme Q10 supplementation on clinical features of migraine: a systematic review and dose-response meta-analysis of randomized controlled trials.
    Parohan M, Sarraf P, Javanbakht MH, Ranji-Burachaloo S, Djalali M.
    Nutr Neurosci; 2020 Nov 12; 23(11):868-875. PubMed ID: 30727862
    [Abstract] [Full Text] [Related]

  • 15. Open label trial of coenzyme Q10 as a migraine preventive.
    Rozen TD, Oshinsky ML, Gebeline CA, Bradley KC, Young WB, Shechter AL, Silberstein SD.
    Cephalalgia; 2002 Mar 12; 22(2):137-41. PubMed ID: 11972582
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention.
    Murphy JJ, Heptinstall S, Mitchell JR.
    Lancet; 1988 Jul 23; 2(8604):189-92. PubMed ID: 2899663
    [Abstract] [Full Text] [Related]

  • 20. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R, O'Carroll P, Dexter K, Freitag F, Shade CL.
    Headache; 2014 Jan 23; 54(1):67-79. PubMed ID: 24021029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.